Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6537426 | 0.84 | PTGES (0.50) | PTGESRXFP1 | |
| SCHEMBL6537987 | 0.84 | PTGES (0.47) | PTGESRXFP1 | |
| SCHEMBL6537358 | 0.83 | KDM4E (0.50) | — | |
| SCHEMBL6537695 | 0.83 | PTGES (0.44) | PTGES | |
| SCHEMBL6537593 | 0.82 | PTGES (0.46) | PTGESRXFP1 | |
| SCHEMBL6537998 | 0.80 | PTGES (0.45) | PTGESRXFP1 | |
| SCHEMBL8486940 | 0.75 | PTGES (0.45) | PTGESRXFP1 | |
| SCHEMBL6537820 | 0.74 | RXFP1 (0.45) | PTGESRXFP1 | |
| SCHEMBL6538002 | 0.74 | RXFP1 (0.45) | PTGESRXFP1 | |
| SCHEMBL6537759 | 0.74 | PTGES (0.44) | PTGES |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0876345-B1 | HETEROCYCLIC COMPOUNDS AS H+-ATPASES | FUJISAWA PHARMACEUTICAL CO (JP) | 2004-08-18 | — | — | EP | disclosed |
| US-6008230-A | TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-12-28 | — | — | US | disclosed |
| EP-0876345-A1 | HETEROCYCLIC COMPOUNDS AS H+-ATPASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997014681-A1 | HETEROCYCLIC COMPOUNDS AS H+-ATPASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-24 | — | — | WO | disclosed |